Metabolic acidosis as a uremic toxin

Area of Science:

• Nephrology
• Biochemistry
• Physiology

Background:

• Chronic renal failure (CRF) is associated with muscle wasting, characterized by loss of lean body mass and negative nitrogen balance.
• Metabolic acidosis is increasingly recognized as a significant contributor to the pathophysiology of muscle wasting in CRF.

Purpose of the Study:

• To investigate the role of metabolic acidosis in initiating muscle wasting syndrome in patients with chronic renal failure.
• To elucidate the molecular mechanisms by which metabolic acidosis contributes to protein catabolism.
• To explore the therapeutic implications of correcting metabolic acidosis in uremic patients.

Main Methods:

• The study reviews existing evidence and findings related to metabolic acidosis in chronic renal failure.
• Mechanisms investigated include the activation of the cytosolic ubiquitin-proteasome proteolytic pathway.
• Alterations in vitamin D and parathyroid hormone levels associated with metabolic acidosis were also examined.

Main Results:

• Metabolic acidosis plays a major role in initiating muscle wasting in chronic renal failure patients.
• Metabolic acidosis mitigates its effects by activating the cytosolic ubiquitin-proteasome proteolytic pathway, leading to protein degradation.
• Metabolic acidosis is also linked to altered vitamin D and parathyroid hormone levels.

Conclusions:

• Correction of metabolic acidosis with alkali therapy, such as sodium bicarbonate supplements, has significant therapeutic potential.
• Alkali therapy can help mitigate muscle wasting and negative nitrogen balance in uremic patients, even with mild metabolic acidosis.